Sonic Healthcare set to lift stake in Microba to 19.9pc

The Australian Financial Review

06/19

The $12.7 billion diagnostics giant Sonic Healthcare is set to lift its stake in biotech Microba Life Sciences to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising.

Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022.

Loading...

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2544359811"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2544359811\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2544359811?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-19 11:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2544359811","market":"hk","top_or_hot":-1,"title":"Sonic Healthcare set to lift stake in Microba to 19.9pc","media":"The Australian Financial Review","content":"<html><body><div><p>The $12.7 billion diagnostics giant <a href=\"https://laohu8.com/S/SHL.AU\">Sonic Healthcare</a> is set to lift its stake in biotech <a href=\"https://laohu8.com/S/MAP.AU\">Microba Life Sciences</a> to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising.</p><figure><picture><source height=\"220\" media=\"(min-width: 1180px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_220%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_440%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"220\"/><source height=\"240\" media=\"(min-width: 1020px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_240%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_480%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"240\"/><source height=\"240\" media=\"(min-width: 768px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_240%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_480%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"240\"/><img height=\"382\" sizes=\"(max-width: 767px) 382px\" src=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_220%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_382%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_764%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"382\"/></picture><figcaption><p>Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022. <cite> </cite></p></figcaption></figure><div>Loading...<figure></figure><figure></figure><figure></figure><figure></figure></div><div></div></div></body></html>","source":"afr_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonic Healthcare set to lift stake in Microba to 19.9pc</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonic Healthcare set to lift stake in Microba to 19.9pc\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Australian Financial Review</strong><span class=\"h-time small\">2025-06-19 11:19</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div><p>The $12.7 billion diagnostics giant <a href=\"https://laohu8.com/S/SHL.AU\">Sonic Healthcare</a> is set to lift its stake in biotech <a href=\"https://laohu8.com/S/MAP.AU\">Microba Life Sciences</a> to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising.</p><figure><picture><source height=\"220\" media=\"(min-width: 1180px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_220%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_440%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"220\"/><source height=\"240\" media=\"(min-width: 1020px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_240%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_480%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"240\"/><source height=\"240\" media=\"(min-width: 768px)\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_240%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_480%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"240\"/><img height=\"382\" sizes=\"(max-width: 767px) 382px\" src=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_220%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25\" srcset=\"https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_382%2Cq_88%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25, https://static.ffx.io/images/$zoom_0.277%2C$multiply_3%2C$ratio_1%2C$width_378%2C$x_110%2C$y_0/t_crop_custom/c_scale%2Cw_764%2Cq_52%2Cf_auto/189f4ebe7ee775c7b48c76422973273a8a1b7c25 2x\" width=\"382\"/></picture><figcaption><p>Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022. <cite> </cite></p></figcaption></figure><div>Loading...<figure></figure><figure></figure><figure></figure><figure></figure></div><div></div></div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://www.afr.com/street-talk/sonic-healthcare-set-to-lift-stake-in-microba-to-19-9pc-20250619-p5m8rg\">The Australian Financial Review</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"綜合支持服務","start_time":0,"source_url":"https://www.afr.com/street-talk/sonic-healthcare-set-to-lift-stake-in-microba-to-19-9pc-20250619-p5m8rg","article_id":"2544359811","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2544359811","pubTimestamp":1750303140,"columns":[],"sourceInfo":{"source_id":"afr_stock","name":"The Australian Financial Review"},"weMediaInfo":null,"summary":"The $12.7 billion diagnostics giant Sonic Healthcare is set to lift its stake in biotech Microba Life Sciences to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising.Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022. Loading...","collect":0,"end_time":0,"defaultTopTitle":"afr.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","SHL.AU":"SONIC HEALTHCARE LTD","HCSG":"Healthcare Svcs Group Inc"},"translate_title":"Sonic Healthcare将把Microba股份增至19.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1,"SHL.AU":1},"content_text":"The $12.7 billion diagnostics giant Sonic Healthcare is set to lift its stake in biotech Microba Life Sciences to 19.9 per cent, the maximum permissible shareholding allowed in a listed company in absence of a takeover bid, as part of an equity raising.Microba Life Sciences chairman Ian Frazer, CEO Luke Reid and co-founder Gene Tyson at the listing ceremony in April 2022.  Loading...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}